Pictet & Cie (Europe) Sa Sarepta Therapeutics, Inc. Transaction History
Pictet & Cie (Europe) Sa
- $4.53 Billion
- Q4 2024
A detailed history of Pictet & Cie (Europe) Sa transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Pictet & Cie (Europe) Sa holds 2,467 shares of SRPT stock, worth $280,547. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,467
Previous 2,827
12.73%
Holding current value
$280,547
Previous $353,000
15.3%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding SRPT
# of Institutions
525Shares Held
84.4MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.17 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.02 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$712 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$496 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$486 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.96B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...